The effects of the glucocorticoids prednisolone, deflazacort and beclomethasone-dipropionate on the RM 3/1 macrophage in human peripheral blood

Skin Pharmacology and Applied Skin Physiology

Volumn 11, Issue 4-5, 1998, Pages 227-231

  Zwadlo Klarwasser, Gabriele ^a   Schmutzler, Wolfgang ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Glucocorticoid potency; Inhalative; Macrophages monocytes; Oral

Indexed keywords

BECLOMETASONE; DEFLAZACORT; GLUCOCORTICOID; PREDNISOLONE;

ADULT; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; MACROPHAGE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; FEMALE; HUMANS; LEUKOCYTE COUNT; MACROPHAGES; MALE; MIDDLE AGED; PREDNISOLONE; PREGNENEDIONES;

EID: 0032465999     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029831     Document Type: Article

References (18)

1. Barnes PJ, Adcock I: Anti-inflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol Sci 1993;14:436-441.
2. Schleimer RP: An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993;45(suppl 1):S3-S7.
3. Hamann W, Flöter A, Schmutzler W, Zwadlo-Klarwasser G: Characterization of a novel anti-inflammatory factor produced by RM 3/1 macrophages derived from glucocorticoid treated human monocytes. Inflamm Res 1995;44:535-540.
4. Zwadlo G, Voegeli R, Schulze-Osthoff K, Sorg C: A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp Cell Biol 1987;55:295-304.
5. Zwadlo-Klarwasser G, Bent S, Haubeck HD, Sorg C, Schmutzler W: Glucocorticoid-induced appearance of the macrophage subtype RM 3/1 in the peripheral blood of man. Int Arch Allergy Immunol 1990;91:175-180.
6. + macrophage in human blood. Int Arch Allergy Immunol 1991;94:278-279.
7. Zwadlo-Klarwasser G, Neubert R, Stahlmann R, Schmutzler W: Influence of dexamethasone on the RM 3/1 positive macrophages in the peripheral blood and tissues of a new world monkey (the marmoset Callithrix jacchus). Int Arch Allergy Immunol 1992;97:178-180.
8. O'Connell SL, Tresham J, Fortune CL, Farrugia W, McDougall JG, Scoggins BA, Wark JD: Effects of prednisolone and deflazacort on osteocalcin metabolism in sheep. Calcif Tissue Int 1993;53:117-121.
9. Omote M, Sakai K, Mizusawa H: Acute effects of deflazacort and its metabolite 21-desacteyl-deflazycort on allergic reactions. Drug Res 1994;44:149-153.
10. Stellato C, Casolaro V, Renda A, Genovese A, Marone G: Anti-inflammatory effect of deflazacort. Int Arch Allergy Immunol 1992;99:340-342.
11. Markham A, Bryson HM: Deflazacort: A review of its pharmacological properties and therapeutic efficacy. Drugs 1995;50:317-333.
12. Böyum A: Isolation of mononuclear cells and granulocytes from human blood. J Clin Lab Invest 1968;21:S77-S79.
13. Topoll HH, Zwadlo G, Lange DE, Sorg C: Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis. J Periondontal Res 1989;24:106-112.
14. Zwadlo-Klarwasser G, Kauhl W, Schmitz C, Hettich R: Influence of severe burn injury on the expression of RM 3/1 and HLA-DR antigens in human blood monocytes. J Burn Care Rehabil 1996;17:287-293.
15. Babadjanova G, Allolio B, Vollmer M, Reincke M, Schulte HM: Comparison of the pharmacodynamic effects of deflazacort and prednisolone in healthy subjects. Eur J Clin Pharmacol 1996;51:53-57.
16. Mollmann H, Hochhaus G, Rohatagi S, Barth J, Derendorf H: Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone. Pharm Res 1995;12:1096-1100.
17. Barnes NC: Safety of high-dose inhaled corticosteroids. Respir Med 1993;87(suppl A):27-31.
18. Nolte D: Inhalative Kortikosteroid-therapie; in Nolte D (ed): Asthma: Das Krankheitsbild, der Asthmapatient, die Therapie. Gilching b. München, Urban & Schwarzenberg, 1995, pp 213-217.